SA close to meeting TB research funding targets, but most countries falling short

SA close to meeting TB research funding targets, but most countries falling short

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • SA close to meeting TB research funding targets, but most countries falling short

    South Africa is one of only six countries to ever meet their “fair share target” for funding tuberculosis (TB) research, according to a new report. In absolute terms however, South Africa’s contribution is small change compared to investments into TB research made by the top two contributors, the United States government and the Bill and…

    ·

  • Integrating HIV and NCD care is critical but not straight-forward, clinicians say

    With the remarkable success of antiretroviral treatment people living with HIV in South Africa are generally living much longer than they did two decades ago. As a result, more people with HIV are also now living with non-communicable diseases (NCDs) such as diabetes and hypertension. Accordingly, the need to better integrate HIV and NCD services…

    ·

  • SA can’t afford proposed cuts to HIV funding

    National Treasury has proposed a R1 billion cut to HIV funding. This has come about because – rather than seeing the reduced price of antiretroviral treatment as an opportunity to scale up treatment coverage and strengthen other interventions to address the HIV epidemic – the Department of Health has seen it as an opportunity for…

    ·

  • From a pig farm in Zim to star HIV researcher- Prof Linda-Gail Bekker reflects on her remarkable journey

    Inside Professor Linda-Gail Bekker’s office a bookshelf is stacked with titles on general medicine, HIV and tuberculosis. Against the bookshelf, a mannequin leans dressed in a white doctor’s coat, sparkling tiara and pink Venetian mask, with a stethoscope protruding from her pocket. Known to colleagues as LGB, Bekker is one of South Africa’s top HIV…

    ·

  • Amid budget constraints, tough choices for SA’s HIV response

    Around 13% of South Africa’s population are living with HIV and the country has the world’s largest HIV treatment programme. The country’s finances are however under huge pressure and significant cuts were recently announced to government’s HIV budget. Catherine Tomlinson unpacks what a new HIV Investment Case can tell us about the possible paths forward.

    ·

  • Lead poisoning part 2 | Scientists find toxic metals in kitchenware

    In part one of this Spotlight special series on lead poisoning, Jesse Copelyn explored new research suggesting that lead exposure is far more damaging to cardiovascular health than previously estimated. In part two, he takes a look at the sources of lead poisoning in South Africa, where the metal has been found in products ranging…

    ·

  • Antibiotic slashes risk of drug-resistant TB in kids, finds major SA study

    Tuberculosis (TB) preventive therapy has been transformed in recent years, with treatment duration having been cut from six or more months to just three or one. Progress in developing new treatments to prevent drug-resistant forms of TB has however lagged behind, especially in children. Elri Voigt unpacks findings from a major new TB prevention study…

    ·

  • “Someone had to do it”, says SA TB activist on Time 100 list

    At the age of 19 Phumeza Tisile contracted multidrug-resistant tuberculosis. For four years she battled the disease, losing her hearing in the process. At one stage, a doctor told her to visit a priest and prepare her soul for death. Recently, Tisile (now 33) made it on to TIME magazine’s 2023 TIME100 Next list, as…

    ·

  • Lead poisoning part 1 | What is behind the shocking number of deaths?

    Evidence suggests that even the tiniest amount of lead is detrimental to our health – and that’s bad news for people in South Africa, who are exposed to large amounts of the metal. Jesse Copelyn explores why lead does so much damage to the brain and heart, and why scientists keep finding it’s worse than…

    ·

  • SA’s remarkable TB clinical trial capacity

    Several of the world’s most important tuberculosis clinical trials of the last two decades were done in part or entirely in South Africa. Tiyese Jeranji chatted to some leading researchers about where the country’s clinical trial capacity comes from and what is needed to maintain and improve it.

    ·